drugset / Trial / NCT02562807
A Study of TAS-303 in Female Patients With Stress Urinary Incontinence
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate pharmacological effect, safety and pharmacokinetic of TAS-303 in female patients with Stress Urinary Incontinence.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-12
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PARENT OF TAS-303 | Small molecule | 9 mg | — |
| Comparator | PARENT OF TAS-303 | Small molecule | 18 mg | — |